Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicolette Drescher"'
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 24, Iss , Pp 113-117 (2022)
Numerous radiation oncology residents and junior attendings have identified common weaknesses in residency training that hinder the transition from training to independent practice. Recurrent themes include not only general autonomy but also proficie
Externí odkaz:
https://doaj.org/article/11b4d793c3934f54b86b808cb0641eff
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 25, Iss , Pp 100202- (2023)
Externí odkaz:
https://doaj.org/article/0f850298c8904e1e840c72b50aa3d6c9
Autor:
Nima Aghdam, Abigail N. Pepin, Michael Creswell, Kristin Hsieh, Clayton Smith, Nicolette Drescher, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Deepak Kumar, Brian Timothy Collins, Jonathan W. Lischalk, Pranay Krishnan, Simeng Suy, John Lynch, Guarav Bandi, Ryan Andrew Hankins, Sean P. Collins
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Stereotactic body radiation therapy (SBRT) is a safe and effective treatment option for patients with low to intermediate risk prostate cancer (1). SBRT results in very low PSA nadirs secondary to the delivery of high biologically effecti
Externí odkaz:
https://doaj.org/article/06aed92f2e1f4b29b347dfd2fd798858
Autor:
Alexandra De Leo, Nicolette Drescher, Fantine Giap, Ryan Brisson, Matthew Culbert, Vincent Cassidy, Anamaria Yeung
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e16
Autor:
Brian T. Collins, Clayton S. Smith, Deepak Kumar, Kristin Hsieh, Jonathan W. Lischalk, Abigail Pepin, Siyuan Lei, Nima Aghdam, Marilyn Ayoob, Ryan Andrew Hankins, Nicolette Drescher, Simeng Suy, Sean P. Collins, Pranay Krishnan, Guarav Bandi, Thomas M. Yung, Malika Danner, John H. Lynch, Michael Creswell
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Background: Stereotactic body radiation therapy (SBRT) is a safe and effective treatment option for patients with low to intermediate risk prostate cancer (1). SBRT results in very low PSA nadirs secondary to the delivery of high biologically effecti
Autor:
Sean P. Collins, Siyuan Lei, Nicolette Drescher, Deepak Kumar, J.W. Lischalk, Marilyn Ayoob, John J. Lynch, Anatoly Dritschilo, Malika Danner, Brian T. Collins, Nima Aghdam, Simeng Suy, Thomas M. Yung
Publikováno v:
Journal of Clinical Oncology. 37:66-66
66 Background: SBRT is a safe and effective treatment option for patients with low to intermediate risk prostate cancer (PCa). SBRT delivers high biologically effective doses resulting in very low PSA nadirs. Strategies to diagnose and confirm salvag